je.st
news
Opko Spots Another Overlooked Opportunity In MabVax Therapeutics
2015-04-08 23:11:32| Biotech - Topix.net
MabVax has a pipeline consisting of two Phase II cancer vaccines, a novel antibody discovery platform, an existing relationship with Juno Therapeutics, and an enticing value proposition. Opko Health has a history of discerning overlooked assets in which to make strategic investments prior to value creation.
Tags: opportunity
spots
overlooked
therapeutics
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||